eg: UK or Brides UK or Classical Art or Buy Music or Spirituality
 
eg: UK or Brides UK or Classical Art or Buy Music or Spirituality
 

Your Online Guide » Legal Guide » Patent and Trademark

Pfizer Keeps Viagra Patent. Generics Still A No No.
by Thomas H. Lindblom, Tho
The court found that Apotex will not be able to sell a generic form of the patented product until 2014, as it would be an infringement of Pfizer's rights, reports Bloomberg.

However, spokesperson for Apotex Elie Betito has confirmed to the news source that the company will be appealing against the decision.

"We're definitely moving to the next level. Taking the case to Canada's federal court of appeal will be pursued in line with the company's goal of providing affordable medication to patients," he said.

This case once again brings to the fore the issue of generic treatments for ED. Betito has a valid point when he says that the availability of generics lowers the price of medicine to the consumer. A generic medicine is typically 20% to 80% less expensive than the brand-name original. In addition, the availability of lower-priced generic medicines brings down the price of originator drugs through market competition, producing even further savings to patients. Allowing effective competition between generic medicines and patent-expired original brands is crucial to lowering pharmaceutical costs and stimulating innovation.

However, this said, Pfizer still holds the exclusive rights to Viagra. It is not a patent expired brand and yet, as it stands there are many troubling issues surrounding generic Viagra due to the easy access to an abundance of illegal suppliers on the internet breaking the patent ownership.

As Pfizer fight to protect the patent on the famous ED treatment in the courts against legitimate suppliers such as Apotex, millions of small backyard operations are busily producing Viagra for sale on the web. These operations operate with low overhead and labour costs and are frequently based in developing countries. Most worryingly of all, generic Viagra is produced without any regulatory oversight.

While generic medicines should comply with the same strict standards of quality, safety and efficacy as original pharmaceutical products, this is often not the case. The lack of an independent monitory organization means that there is a high probability that the treatment will not work or could even prove detrimental to one's health.
As demonstrated by the case in Canada, Pfizer's patent is still exclusive, therefore any production of generic Viagra remains illegal.
This information has been brought to you by Firstmed.co.uk, a UK registered pharmacy specialising in the supply of genuine and branded ED treatments, including .

If you wish to discuss any of the above issues in more detail, do not hesitate to contact info@firstmed.co.uk or call +44 (0)870 199 5287
.
- Address: Firstmed Consulting
PO Box 50227
Thomas H. Lindblom has sinced written about articles on various topics from Health, About Web Hosting and Pets. Firstmed is the leading online male ED pharmacy in the UK and specialises in genuine, branded Viagra, and other leading ">impotence treatments. Thomas H. Lindblom's top article generates over 110000 views. to your Favourites.
EditorialToday Legal Guide has 6 sub sections. Such as Compensation Laws, Medical Malpractice Law, Law Order, About Drinking & Driving, IP Law and New Bankruptcy Law. With over 20,000 authors and writers, we are a well known online resource and editorial services site in United Kingdom, Canada & America . Here, we cover all the major topics from self help guide to A Guide to Business, Guide to Finance, Ideas for Marketing, Legal Guide, Lettre De Motivation, Guide to Insurance, Guide to Health, Guide to Medical, Military Service, Guide to Women, Pet Guide, Politics and Policy , Guide to Technology, The Travel Guide, Information on Cars, Entertainment Guide, Family Guide to, Hobbies and Interests, Quality Home Improvement, Arts & Humanities and many more.
About Editorial Today | Contact Us | Terms of Use | Submit an Article | Our Authors